To cure or not to cure: consequences of immunological interactions in CML treatment
From MaRDI portal
Publication:2002115
Recommendations
- Stability analysis of a model of interaction between the immune system and cancer cells in chronic myelogenous leukemia
- A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction
- A mathematical model of Imatinib and interferon-Alpha combined treatment of chronic myeloid leukemia
- Stability analysis of a mathematical model for chronic myeloid leukemia eradication
- A quantitative study on the role of TKI combined with Wnt/\(\beta\)-catenin signaling and IFN-\(\alpha\) in the treatment of CML through deterministic and stochastic approaches
Cites work
- A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction
- Algorithms in real algebraic geometry
- Interactions between the immune system and cancer: A brief review of non-spatial mathematical models
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- Post-transplantation dynamics of the immune response to chronic myelogenous leukemia
- Stability analysis of a model of interaction between the immune system and cancer cells in chronic myelogenous leukemia
- Strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia
Cited in
(8)- Dynamics and bifurcations in a model of chronic myeloid leukemia with optimal immune response windows
- Modelling of killer T-cell and cancer cell subpopulation dynamics under immuno- and chemotherapies
- Post-transplantation dynamics of the immune response to chronic myelogenous leukemia
- Strategic treatment interruptions during imatinib treatment of chronic myelogenous leukemia
- Ultimate dynamics analysis of the 5D structural leukemia model and partitioning of the parameter space
- Questions from the fourth son: a clinician reflects on immunomonitoring, surrogate markers and systems biology
- Tumor microenvironment as a metapopulation model: the effects of angiogenesis, emigration and treatment modalities
- Influence of the age structure on the stability in a tumor-immune model for chronic myeloid leukemia
This page was built for publication: To cure or not to cure: consequences of immunological interactions in CML treatment
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2002115)